FDA Inspection 910813 — Carter BloodCare at Keller
The FDA completed an inspection of Carter BloodCare at Keller on January 21, 2015 in Keller, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 21, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Keller, TX (United States)